NCT03424356

Brief Summary

Cystoscopy is a simple, effective and reliable method in current urological practice. Anesthesia may be required in cystoscopy for therapeutic purpose, however it may not be necessary for diagnostic cystoscopy. General anesthesia, spinal anesthesia, epidural anaesthesia and senile block methods may be performed in therapeutic cystoscopy. Pain is main reason of failed cystoscopy. Sedo-analgesia and LMA are generally used for diagnostic cystoscopies. LMA is mostly placed under general anesthesia with the combination of propofol-fentanyl and volatile anesthetics. There is no need for muscle relaxant administration in LMA placement, as it is necessary for intubation. However if muscle relaxant is not used, side effects like hiccup, straining, cough, undesirable muscle movement, hypoxia and laryngeal spasm may be observed. For the improvement of the patient comfort the use of effective muscle relaxants are described in several studies in literature. This study aimed to reveal the quality of anesthesia, hemodynamics, surgical comfort, extra propofol need and recovery time while low dose of muscle relaxant rocuronium was added to propofol-fentanyl combination for LMA placement.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
96

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 4, 2017

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

November 15, 2017

Completed
3 months until next milestone

First Posted

Study publicly available on registry

February 7, 2018

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 4, 2018

Completed
6 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2018

Completed
Last Updated

June 13, 2018

Status Verified

June 1, 2018

Enrollment Period

1.9 years

First QC Date

November 15, 2017

Last Update Submit

June 12, 2018

Conditions

Keywords

LMARocuronium bromurpropofol

Outcome Measures

Primary Outcomes (1)

  • questionnaire

    The quality of LMA placement with or without neuromusculer drug.

    up to first 60 minutes

Secondary Outcomes (1)

  • questionnaire

    up to first 24 hours

Study Arms (2)

lma with rocuronium bromide

EXPERIMENTAL

In study group, 2-3 mg/kg propofol, 1mcg/kg fentanyl and 0.15 mg/kg rocuronium bromide will be administered during lma insertion in cystoscopy procedure.

Drug: Rocuronium BromideDrug: FentanylDrug: PropofolProcedure: cystoscopy

lma with saline solution

ACTIVE COMPARATOR

In control group, 2-3 mg/kg propofol, 1 mcg/kg fentanyl and saline(no rocuronium) will be administered during lma insertion in cystoscopy procedure.

Drug: Saline SolutionDrug: FentanylDrug: PropofolProcedure: cystoscopy

Interventions

0.15 mg/kg rocuronium bromide

Also known as: nueromusculer blocker
lma with rocuronium bromide

1-2 ml saline solution

Also known as: saline
lma with saline solution

1mcg/kg for induction

Also known as: narcotic analgesic
lma with rocuronium bromidelma with saline solution

2-3mg/kg for anaesthetic induction

Also known as: hypnotic agent
lma with rocuronium bromidelma with saline solution
cystoscopyPROCEDURE

patients will treated with this surgical procedure

Also known as: surgical prosedure
lma with rocuronium bromidelma with saline solution

Eligibility Criteria

Age18 Years - 80 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male patients
  • ASA I-II patients
  • Cystoscopy patients
  • patients entubated with lariyngeal mask

You may not qualify if:

  • Female patients
  • Asa III-IV patients
  • Surgery duration is more than 2 hours
  • Drug abusers
  • Non compromising patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Erciyes University

Kayseri, 38039, Turkey (Türkiye)

RECRUITING

MeSH Terms

Interventions

RocuroniumSaline SolutionSodium ChlorideFentanylNarcoticsPropofolHypnotics and SedativesCystoscopy

Intervention Hierarchy (Ancestors)

AndrostanolsAndrostanesSteroidsFused-Ring CompoundsPolycyclic CompoundsCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical PreparationsChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium CompoundsPiperidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsCentral Nervous System DepressantsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and UsesAnalgesicsSensory System AgentsPeripheral Nervous System AgentsCentral Nervous System AgentsTherapeutic UsesPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsEndoscopyDiagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisDiagnostic Techniques, UrologicalMinimally Invasive Surgical ProceduresSurgical Procedures, OperativeUrologic Surgical ProceduresUrogenital Surgical Procedures

Study Officials

  • ayşe ülgey, md

    TC Erciyes University

    STUDY CHAIR

Central Study Contacts

mustafa asan, md

CONTACT

ayse ülgey, md

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SCREENING
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor

Study Record Dates

First Submitted

November 15, 2017

First Posted

February 7, 2018

Study Start

January 4, 2017

Primary Completion

December 4, 2018

Study Completion

December 10, 2018

Last Updated

June 13, 2018

Record last verified: 2018-06

Locations